Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 11/2019

01-11-2019 | Acidosis | Letter to the Editor

Fatal type B lactic acidosis in a patient with end-stage liver disease related to homozygous sickle cell disease

Authors: Véronique Masy, Etienne Sokal, Nadejda Ranguelov, Bénédicte Brichard, Pierre-François Laterre, Philippe Hantson

Published in: Annals of Hematology | Issue 11/2019

Login to get access

Excerpt

Hepatic involvement by sickle cell disease (SCD) can result in a variety of symptoms ranging from mild to life-threatening. Acute intrahepatic cholestasis is a rare but often fatal condition, with multi-organ failure as a terminal event. The following observation is suggesting that extreme hyperbilirubinemia may be associated with energetic failure. …
Literature
1.
Finsterer J, Scorza FA (2017) Effects of antiepileptic drugs on mitochondrial functions, morphology, kinetics, biogenesis, and survival. Epilepsy Res. 136:5–11CrossRef
2.
Lipka K, Bülow HH (2003) Lactic acidosis following convulsions. Acta Anaesthesiol Scand. 47:616–618CrossRef
3.
Karacaoglu PK, Asma S, Korur A et al (2016) East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients. Ann Hematol. 95:993–1000CrossRef
4.
Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J Jr, Shah AK, Mankad VN, Investigators of the Cooperative Study of Sickle Cell Disease (2003) Causes of death in sickle cell disease: an autopsy study. Br J Haematol. 123:359–365CrossRef
5.
Haydek JP, Taborda C, Shah R, Reshamwala PA, McLemore M, Rassi FE, Chawla S (2019) Extreme hyperbilirubinemia: an indicator of morbidity and mortality in sickle cell disease. World J Hepatol. 11:287–293CrossRef
Metadata
Title
Fatal type B lactic acidosis in a patient with end-stage liver disease related to homozygous sickle cell disease
Authors
Véronique Masy
Etienne Sokal
Nadejda Ranguelov
Bénédicte Brichard
Pierre-François Laterre
Philippe Hantson
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 11/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-019-03822-8

Other articles of this Issue 11/2019

Annals of Hematology 11/2019 Go to the issue

Original Article

Comparison of calcineurin inhibitors in combination with conventional methotrexate, reduced methotrexate, or mycophenolate mofetil for prophylaxis of graft-versus-host disease after umbilical cord blood transplantation

Original Article

Hematocrit levels and thrombotic events in patients with polycythemia vera: an analysis of Veterans Health Administration data

Review Article

Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis

Original Article

Efficacy and safety of micafungin in unrelated cord blood transplant recipients

Letter to the Editor

Reversal of skin changes in smoldering myeloma with clinical presentation of POEMS syndrome with a lenalidomide-based regimen

Original Article

A CARD9 single-nucleotide polymorphism rs4077515 is associated with reduced susceptibility to and severity of primary immune thrombocytopenia

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits